Walgreens Boots Alliance (NASDAQ:WBA) Given New $10.00 Price Target at Evercore ISI

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective lowered by Evercore ISI from $17.00 to $10.00 in a research report released on Friday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the pharmacy operator’s stock.

Other analysts have also issued reports about the stock. Barclays lowered their price objective on shares of Walgreens Boots Alliance from $21.00 to $19.00 and set an underweight rating for the company in a report on Monday, June 24th. TD Cowen dropped their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating on the stock in a research report on Wednesday, April 3rd. UBS Group decreased their price objective on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a report on Monday, June 24th. Raymond James restated a market perform rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating for the company in a research note on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Hold and a consensus price target of $19.00.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $11.58 on Friday. The business has a 50 day moving average of $16.49 and a 200 day moving average of $20.14. Walgreens Boots Alliance has a 52 week low of $11.48 and a 52 week high of $31.32. The company has a market cap of $10.00 billion, a PE ratio of -1.72, a P/E/G ratio of 0.82 and a beta of 0.72. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. During the same period in the previous year, the firm posted $1.00 earnings per share. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, equities research analysts forecast that Walgreens Boots Alliance will post 2.94 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 8.64%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.84%.

Insider Activity

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 17.40% of the company’s stock.

Institutional Trading of Walgreens Boots Alliance

A number of large investors have recently made changes to their positions in the stock. Quadrant Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 33.8% in the fourth quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock worth $196,000 after purchasing an additional 1,893 shares during the last quarter. Syon Capital LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $333,000. New York Life Investment Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock worth $3,008,000 after buying an additional 690 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $297,000. Finally, Corient Private Wealth LLC increased its position in Walgreens Boots Alliance by 38.9% during the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock valued at $7,325,000 after acquiring an additional 78,523 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.